Target Therapy Using a Small Molecule Inhibitor against Angiogenic Receptors in Pancreatic Cancer

This publication has 49 references indexed in Scilit:

• A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
  New England Journal of Medicine, 2004
• Antiangiogenic activity of genistein in pancreatic carcinoma cells is mediated by the inhibition of hypoxia‐inducible factor‐1 and the down‐regulation of VEGF gene expression
  Cancer, 2003
• Pancreatic cancer growth is inhibited by blockade of VEGF-RII
  Surgery, 2003
• VEGF-RII Influences the Prognosis of Pancreatic Cancer
  Annals of Surgery, 2002
• Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours
  European Journal of Cancer, 2002
• Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
  Science, 1999
• Pancreatic cancer cells selectively stimulate islet β cells to secrete amylin
  Gastroenterology, 1998
• Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation
  European Journal of Cancer, 1996
• Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
  Biochemical and Biophysical Research Communications, 1992
• The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth Factor
  Science, 1992